Please assess the completion status of the following clinical trial:

Trial Title: Quadratus Lumborum Block for Post-Cesarean Analgesia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Elective cesarean delivery~* American Society of Anesthesiologists Physical Status 1-3~* Suitable for procedure to be carried out under spinal anesthesia~Exclusion Criteria:~* Inability to give informed consent or to co-operate with post-operative evaluation~* Allergy to local anesthetics, morphine, fentanyl, ropivacaine~* Ongoing major medical or psychiatric problems~* Chronic opioid use~* Major coagulopathy~* BMI\>35 on first ante natal visit~* Pre-eclampsia~* Contraindication to neuraxial anesthesia

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: SHAM_COMPARATOR): Group 1 will receive intrathecal morphine co-administered with the spinal anesthetic. After the completion of surgery, bilateral ultrasound guided Sham Block be done with 25 mL of saline per side.
- Group 2 (Type: ACTIVE_COMPARATOR): Group 2 will receive an equivalent volume of intrathecal saline co-administered with the spinal anesthetic. After surgery, bilateral ultrasound guided Quadratus Lumborum Block will be performed with 25 ml 0.5% Ropivacaine per side.
- Group 3 (Type: ACTIVE_COMPARATOR): Group 3 will receive will receive intrathecal morphine with the spinal anesthetic. After the completion of surgery, bilateral ultrasound guided Quadratus Lumborum Block will be performed with 25 ml 0.5% Ropivacaine per side.

Based on this trial design, predict the completion outcome and termination type (if applicable).